Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENTECAVIR for Hepatitis b reactivation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 63 adverse event reports in the FDA FAERS database where ENTECAVIR was used for Hepatitis b reactivation.

Most Reported Side Effects for ENTECAVIR

Side Effect Reports % Deaths Hosp.
Drug resistance 312 7.0% 9 61
Death 298 6.6% 290 27
Drug ineffective 207 4.6% 22 32
Hepatitis b 166 3.7% 64 17
Off label use 129 2.9% 10 36
Maternal exposure during pregnancy 126 2.8% 5 8
Viral mutation identified 121 2.7% 3 8
Renal impairment 118 2.6% 1 38
Pathogen resistance 115 2.6% 2 12
Fatigue 108 2.4% 6 16
Hepatic cancer 94 2.1% 28 19
Hepatocellular carcinoma 94 2.1% 41 40
Hospitalisation 88 2.0% 3 75
Hepatic failure 86 1.9% 72 22
Drug dose omission 82 1.8% 0 4

Other Indications for ENTECAVIR

Hepatitis b (1,583) Product used for unknown indication (1,035) Chronic hepatitis b (705) Antiviral prophylaxis (64) Hepatic cirrhosis (57) Hepatitis (49) Hepatitis viral (42) Hiv infection (42) Prophylaxis (42) Chronic hepatitis c (41)

Other Drugs Used for Hepatitis b reactivation

TENOFOVIR DISOPROXIL (48) LAMIVUDINE (27) TENOFOVIR ALAFENAMIDE (21) TENOFOVIR (18) METHYLPREDNISOLONE (5)

Related Pages

ENTECAVIR Full Profile All Hepatitis b reactivation Drugs ENTECAVIR Demographics ENTECAVIR Timeline